ReviewCancers2020

Bispecific Chimeric Antigen Receptor T Cell Therapy for B Cell Malignancies and Multiple Myeloma.

Robert J Cronk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.